Navigation Links
Unilife on Schedule to Fill Initial Orders for Unifill Syringe
Date:3/15/2011

YORK, Pa., March 15, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (Nasdaq: UNIS; ASX: UNS) today announced that it remains on schedule to commence initial production of the Unifill® prefilled syringes later this month, and commence sales to pharmaceutical customers by the end of June 2011.  

Last week the Company successfully commissioned the cleanrooms at its state-of-the-art production facility in York, PA. Following the completion of this essential regulatory milestone, Unilife has now moved toward the final steps required to commence production of its Unifill and Unitract® safety syringe products at its new site. This includes the installation and final qualification of production systems utilized in the assembly of the Unifill syringe. As part of its planning to commence production, Unilife has begun to build up its inventory of components and other materials to be utilized in the assembly of the Unifill syringe.

Once initial production has commenced, Unilife will be able to complete final product qualification activities in the second quarter of the 2011 calendar year.  Accordingly, the Company expects to start filling initial sales orders it has received from existing pharmaceutical customers for the Unifill syringe by late-June 2011.

Unilife has also received requests from a number of other interested pharmaceutical companies for the Unifill syringe as part of ongoing discussions. It is expected that these pharmaceutical companies will purchase the initial production batches to undertake formal evaluations of the device prior to the signing of any commercial agreements with Unilife.

Dr. Ramin Mojdeh, Chief Operating Officer of Unilife, stated, "This is a truly exciting time for everyone associated with Unilife. Having now established the operational capabilities and human expertise necessary t
'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
2. Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter
3. Unilife Corporation to Announce Financial Results for Fiscal 2011 Second Quarter on Monday, February 14, 2011
4. Unilife Appoints Dr. Ramin Mojdeh as Chief Operating Officer
5. Unilife Receives SPP Applications Exceeding A$12.8 Million
6. Unilife Corporation Moves into New State-of-the-Art Manufacturing Facility and Global Headquarters
7. Unilife Completes A$23.1 Million Private Placement
8. Unilife Corporation Announces Financial Results for Fiscal Year 2011 First Quarter
9. Unilife Commences U.S. Sales of Unitract® 1mL Syringes
10. Unilife Corporation Schedules Fiscal 2011 First Quarter Conference Call For Monday, November 15, 2010
11. Unilife Secures U.S. Government Financial Backing for the Completion of New Global Headquarters and Manufacturing Facility in York, PA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... baseball,s all-time hits leader, is the new spokesperson for the ... has announced. "Pete,s a Hall of Famer in ... board with Myoflex," said Ducere Pharma Chief Executive Officer ... known across all generations. The passion and intensity that Pete ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
(Date:1/23/2015)... (NYSE: MNK ) announced today that its ... The open-ended authorization permits the company to repurchase up ... "Funding additional initiatives and seeking attractive business ... pursue a range of focused growth strategies," said ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... DURECT Corporation (Nasdaq: DRRX ) announced today that it has secured a ... million of its registered common stock to Azimuth Opportunity Ltd. for a ... $50 million facility.  DURECT did not pay a commitment fee or ... , , ...
... WASHINGTON , July 1 Hanger Orthopedic ... efforts in response to the January 12th ... alliance of U.S.-based international development and humanitarian nongovernmental organizations. ... Orthopedic Group was nominated by Physicians for Peace, an ...
Cached Medicine Technology:DURECT Corporation Secures $50 Million Committed Equity Financing Facility 2DURECT Corporation Secures $50 Million Committed Equity Financing Facility 3Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction 2Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction 3
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 As interest in ... health care gains momentum worldwide, Rev. Eric J. Hall ... Chaplaincy Network (HCCN), will be the keynote speaker on ... in Israel’s public health system. , The conference, “Hope and ...
(Date:1/22/2015)... 2015 Lower-Auto-Insurance.com has released a new blog post ... car for reducing the costs of an auto insurance policy ... able to get lower prices for their vehicle insurance policies. The ... in determining policy costs. Because of this, drivers should always ...
(Date:12/26/2014)... December 26, 2014 The US represents the ... report. In 2013, GlobalData’s forecast estimates that sales of branded ... market due to the high incidence of the disease, high ... 5EU, Japan, and China. Increased sales of CRC therapies over ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... particles for treatment of diseases. ‘Nano’ refers to billionth ... for treatment of fatal diseases, which will help to ... to develop Nanotechnology in the next 10 years which ... diabetes, Cancer, HIV infection, Alzheimer’s and Parkinson’s diseases. Six ...
... at UCLA had found out the peptides that ward ... more than 20 years ago at UCLA, defensins are ... ward off viruses. However, it was unclear how defensins ... a specific defensin called retrocyclin-2 (RC2) binds to carbohydrate-containing ...
... no sunscreen in spite of staying under direct sunlight for ... spend a significant amount of time practicing and competing in ... are spending so much time in the sun, they have ... them regularly use any form of sunscreen, according to a ...
... that are difficult to handle. Even when so much has ... viral infection has always been a problem. Viral infections ... the disease-causing virus has always been potent enough to escape ... Human Immunodeficiency Virus as it is called has been posing ...
... Immunization (IFFIm) will be providing life saving vaccines for ... project costing $4 billion to be funded by the ... the scheme, the International Finance Facility for Immunization (IFF), ... over the next 10 years and another five million ...
... and Rabia Khatoon's joy knew no bounds when they got ... to pay for the surgery to separate their conjoined twins.// ... thousands of miles away has offered to help us,' Khatoon, ... even as the children get medical attention at New Delhi's ...
Cached Medicine News:Health News:Nanotechnology Revolution To Be Spearheaded By European Union 2Health News:People Still Neglect To Use Sunscreen In Spite Of Cancer Warnings 2Health News:European Countries To Fund $4 Billion For Vaccination For Poor Children’ 2Health News:When A Prince Chose To Help Indian Couple 2
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
... Guidants 20-year history, the VOYAGER RX Dilatation ... treatment outcomes. It combines a new low ... profile shaft,more flexible markers, and short taper ... and tortuous anatomy with even greater confidence, ...
... Coat-A-Count AFP IRMA,is an ... measurement of,alpha-fetoprotein (AFP) in serum. ... vitro use in either of,two ... aid in the,management of patients ...
Enzyme immunoassay for the quantitative determination of ovarian cancer antigen CA125 in human serum...
Medicine Products: